Mucosa-associated but not luminal Escherichia coli is augmented in Crohn’s disease and ulcerative colitis

Gut Pathogens

Josias Rodrigues¹  Rogeria Keller¹  Ligia Yukie Sassaki²  Fernando Gomes Romeiro²  Vanessa R de Carvalho¹  Helton Luis de Souza¹ 

[1] Distrito de Rubião Junior, CEP 18618–970 Botucatu SP Brazil, Laboratory of Medical Bacteriology, Department of Microbiology and Immunology, Institute of Biosciences, State University of São Paulo (UNESP), Sao Paulo, Brazil;Distrito de Rubião Junior, CEP 18618–970 Botucatu SP Brazil, Department of Internal Medicine, Botucatu Medical School, State University of São Paulo (UNESP), Sao Paulo, Brazil

关键词: Ulcerative colitis;    Crohn’s disease;    Virulence;    Bacteria;    Escherichia coli;   

Others  :  833560
DOI  :  10.1186/1757-4749-4-21

 received in 2012-11-23, accepted in 2012-12-09,  发布年份 2012

【 摘 要 】

Background

Escherichia coli is believed to participate in the etiology of Crohn’s disease (CD) and possibly of ulcerative colitis (UC), due at least in part to the observed rise in the number of these bacteria in the gut microbiota of CD and UC patients. Nevertheless, it is not fully understood whether this quantitative variation occurs equally throughout the mucosal and luminal spaces of the gut. To assess this question, stools and mucosa biopsies from distinct intestinal sites were cultured aiming at determining their E. coli concentration. The cultures were additionally screened for the presence of some virulence genes of pathogenic E. coli.

Results

Analyses of clinical materials from 14 controls (38 biopsies and 14 stools samples), 11 CD (25 biopsies and 11 stools samples) and 7 UC patients (18 biopsies and 7 stools samples) indicated no significant variation in the number of E. coli present in stools, but a rise of at least one log₁₀ CFU/mg in biopsies from the ileum of CD patients and the sigmoid and rectum of CD and UC patients. The cultures were screened for the presence of E. coli attaching and effacing (eae), invasion plasmid antigen H (ipaH), aggregative adherence transcriptional activator (aggR), Shiga cytotoxins (stx), and heat labile enterotoxin (elt) and the following serine proteases autotransporters of Enterobacteriaceae (SPATE) genes: plasmid encoded toxin (pet), secreted autotransporter toxin (sat), Shigella extracellular protein (sepA), protein involved in intestinal colonization (pic) and Shigella IgA-like protease homolog (sigA). Six of the 10 genes screened were detected in the total of samples investigated: aggR, eae, pet, sat, sepA and sigA. No difference in the prevalence of any of these markers was observed in cultures from different clinical materials or groups of patients.

Methods

Bacterial quantitation was carried out following cultures of diluted samples suspensions in MacConkey agar, Wilkins Chalgren agar for anaerobes, E. coli/coliform chromocult agar, and blood agar. Screening for E. coli virulence genes was performed by multiplex PCR of DNA purified from total MacConkey undiluted broth cultures.

Conclusion

In CD and UC patients only the mucosa associated population of E. coli is augmented and the proliferation is prominent in the ileum of CD and rectum and sigmoid of both UC and CD patients which are sites where the lesions usually are observed. The augmented E. coli population in these sites presented a low number of the virulence markers, possibly meaning that they are not relevant for the disease process.

【 授权许可】

   
2012 de Souza et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM: Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer. Gastroenterology 2004, 127(1):80-93.
• [2]Sokol H, Lepage P, Seksik P, Dore J, Marteau P: Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol 2006, 44(9):3172-3177.
• [3]Kotlowski R, Bernstein CN, Sepehri S, Krause DO: High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 2007, 56(5):669-675.
• [4]Rhodes JM: The role of Escherichia coli in inflammatory bowel disease. Gut 2007, 56(5):610-612.
• [5]Cartun RW, Van Kruiningen HJ, Pedersen CA, Berman MM: An immunocytochemical search for infectious agents in Crohn’s disease. Mod Pathol 1993, 6(2):212-219.
• [6]Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, Bringer MA, Swidsinski A, Beaugerie L, Colombel JF: High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology 2004, 127(2):412-421.
• [7]Santos ACS, Ohara R, Rodrigues J: Prevalência de Escherichia coli invasoras de células Hep-2 na mucosa intestinal e no lúmen de portadores de doença de Crohn. Santos, Brazil: Poster 32 presented during XXI Latin American Meeting of the ALAM; 2012.
• [8]Rolhion N, Darfeuille-Michaud A: Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis 2007, 13(10):1277-1283.
• [9]Thomazini CM, Samegima DA, Rodrigues MA, Victoria CR, Rodrigues J: High prevalence of aggregative adherent Escherichia coli strains in the mucosa-associated microbiota of patients with inflammatory bowel diseases. IJMM 2011, 301(6):475-479.
• [10]Nataro JP, Steiner T, Guerrant RL: Enteroaggregative Escherichia coli. Emerg Infect Dis 1998, 4(2):251-261.
• [11]Robins-Browne RM: Traditional enteropathogenic Escherichia coli of infantile diarrhea. Rev Infect Dis 1987, 9(1):28-53.
• [12]Nataro JP, Kaper JB: Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998, 11(1):142-201.
• [13]Cooke EM, Ewins SP, Hywel-Jones J, Lennard-Jones JE: Properties of strains of Escherichia coli carried in different phases of ulcerative colitis. Gut 1974, 15(2):143-146.
• [14]Tabaqchali S, O’Donoghue DP, Bettelheim KA: Escherichia coli antibodies in patients with inflammatory bowel disease. Gut 1978, 19(2):108-113.
• [15]Cohavy O, Bruckner D, Gordon LK, Misra R, Wei B, Eggena ME, Targan SR, Braun J: Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun 2000, 68(3):1542-1548.
• [16]Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A, Colombel JF: Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn’s disease. Gastroenterology 1998, 115(6):1405-1413.
• [17]Toma C, Lu Y, Higa N, Nakasone N, Chinen I, Baschkier A, Rivas M, Iwanaga M: Multiplex PCR Assay for Identification of Human Diarrheagenic Escherichia coli. J Clin Microbiol 2003, 41(6):2669-2671.
• [18]Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala’Aldeen D: Type V protein secretion pathway: the autotransporter story. MicrobiolMolecular Biol. Reviews: MMBR 2004, 68(4):692-744.
• [19]Dutta PR, Cappello R, Navarro-Garcia F, Nataro JP: Functional comparison of serine protease autotransporters of Enterobacteriaceae. Infect Immun 2002, 70(12):7105-7113.
• [20]Boisen N, Ruiz-Perez F, Scheutz F, Krogfelt KA, Nataro JP: Short Report: High Prevalence of Serine Protease Autotransporter Cytotoxins among Strains of Enteroaggregative Escherichia coli. AmJTrop Med Hyg 2009, 80(2):294-301.
• [21]Kaper JB, Nataro JP, Mobley HL: Pathogenic Escherichia coli. Nat Rev Microbiol 2004, 2(2):123-140.
• [22]Sands BE: From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004, 126(6):1518-1532.
• [23]Nikolaus S, Schreiber S: Diagnostics of inflammatory bowel disease. Gastroenterology 2007, 133(5):1670-1689.
• [24]Toledo MRF, Fontes CF, Trabulsi LR: EPM - Modificação do meio de Rugai e Araújo para a realização do teste de produção de gás a partir de glicose, H2S, urease e triptofano desaminase. Rev Microbiol São Paulo 1982, 12:309-315.